Abstract:Introduction and Objective The gold standard for the diagnosis of clinicallysignificant portal hypertension isrepresented by HVPG and Upper Gastrointestinalendoscopy is able to indirectlyassess the degree of portalhypertension through the evaluation of esophageal and/or gastric varices. Over the last 20 years, the introduction of non invasive tests (NITs) such asFibroscan has made it possibleto select patients with significantportal hypertension and therefore identify patients eligiblefor endoscopy. The BAVENO VII consensus identifies patientswho could benefit from endoscopy as those patientswith LSM ≥ 20 kPa assessed by TE and platelet count ≤ 150 × 109L. Moreover identifiesvalues of spleen stiffness to rulein and rule out portalhypertension such as SSM >50 kPa and SSM <21 kPa,respectively. Point-shear waveelastography and 2D-shear waveelastography have beenproposed as possible tools to non-invasively assess portalhypertension, but validation of the best cut-off is needed. Aim of this study is the evaluation of the role of 2D-Shear wave in non invasive diagnosis of portalhypertension. Methods From April 2022 to October 2023 we evaluated one hundred patients with chronichepatitis and cirrhosis (50 chronic hepatitis and 50 cirrhosis) whose baseline characteristics are presented in TABLE 1. All patients underwentabdominal ultrasound, liver and spleen stiffness (LS and SS) and liver and spleen 2D-shear wave(L2D-S and S2D-S); FIB-4 and the APRI score were alsocalculated. All cirrhotic patientsunderwent endoscopy to evaluate portal hypertension. Results The prevalence of varices in cirrhotic patients was50%. We found a statisticallysignificant correlation betwen LS and SS (p<0,001) and L2D-S and S2D-S (p<0,001) and the presence of varices, this was true also for APRI and FIB-4 (p<0,001), independently fromage, sex and BMI. We evaluated also the diagnostic performance for each individual test (Table 2), with an optimal cut-off 13.1 kPa and 12.5 kPa for LS and L2D-S (sensitivity 0.83 and 0.79, specificity 0.72 and 0.77, PPV 0.50 and 0.54, NPV 0.93 and 0.92 and AUROC 0.84 and 0.83 respectively), 45 kPa and 25 kPa for SS and S2D-S (sensitivity 0.77 and 0.91, specificity 0.89 and 0.66, PPV 0.69 and 0.47, NPV 0.92 and 0.96 and AUROC 0.88 and 0.80 respectively), 2.82 for FIB-4 (sensitivity 0.84, specificity 0.74, PPV 0.52, NPV 0.93 AUROC 0.80), 0.64 for APRI (sensitivity 0.72, specificity 0.70, PPV 0.44, NPV 0.88 AUROC 0.74). Each single test showed a low PPV for the prediction of oesophagealvarices (OV), however, when we combined the tests together wefound that the combination of LS and S2D-S showed a higher PPV for predicting OV (PPV 0.73; NPV 0.99). Conclusion We foundthat the combination of twotests (Liver stiffness and Spleen stiffness 2D-Shear wave) increases the probability of findingoesophageal varices and therefore can be useful for the non-invasive identification of patients with clinicallysignificant portalhypertension.

Performance of spleen stiffness measurement by 2D-shear wave elastography in evaluating the presence of high-risk varices: comparative analysis of idiopathic portal hypertension versus hepatitis B virus

Portal hypertension in Hepatitis B related Cirrhosis: Diagnostic accuracy of Liver and Spleen stiffness by two-dimensional Shear-wave elastography.

[Diagnostic Accuracy of Liver and Spleen Stiffness by Two Dimensional Shear Wave Elastography for Portal Hypertension in Hepatitis B-related Cirrhosis].

Portal hypertension in hepatitis B‐related cirrhosis: Diagnostic accuracy of liver and spleen stiffness by 2‐D shear‐wave elastography

Spleen and liver stiffness for noninvasive assessment of portal hypertension in cirrhotic patients with large esophageal varices

Spleen stiffness measurement as a non-invasive assessment in patients with portal hypertension

Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC

Evaluation of spleen stiffness by 2D shear wave elastography for ruling out high risk varices in patients with chronic advanced liver disease. A systematic review and meta-analysis

Spleen‐dedicated stiffness measurement performed well to rule out high‐risk varices in HBV‐related hepatocellular carcinoma

Applied research of conventional ultrasound combining shear-wave elastography in posthepatitic cirrhosis patients with portal hypertension

Spleen Thickness Plus Platelets Can Effectively and Safely Screen for High-Risk Varices in Cirrhosis Patients

Spleen stiffness: a new tool to predict high‐risk varices in cirrhotic patients

The Combination of Shear Wave Elastography and Platelet Counts Can Effectively Predict High-Risk Varices in Patients with Hepatitis B-Related Cirrhosis

The role of 2D-Shearwave elastography in non invasive portal hypertension diagnosis

Liver and spleen stiffness measured by acoustic radiation force impulse elastography for noninvasive assessment of liver fibrosis and esophageal varices in patients with chronic hepatitis B.

Point Shear Wave Elastography to Evaluate and Monitor Changing Portal Venous Pressure in Patients with Decompensated Cirrhosis.

Transient Elastography Identifies the Risk of Esophageal Varices and Bleeding in Patients With Hepatitis B Virus–Related Liver Cirrhosis

Study of Virtual Touch Tissue Quantification in Noninvasive Assessment of Esophageal Varices in Patients with Hepatitis B Cirrhosis

Current research status of spleen stiffness measurement in predicting portal hypertension and its complications in patients with liver cirrhosis

Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients

[Combination Measurement of Liver and Spleen Stiffness with Portal Vein Width to Evaluate Risk of Bleeding in Esophageal and Gastric Varices Patients].